BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Manngo PM, Gutschmidt A, Snyders CI, Mutavhatsindi H, Manyelo CM, Makhoba NS, Ahlers P, Hiemstra A, Stanley K, McAnda S, Kidd M, Malherbe ST, Walzl G, Chegou NN. Prospective evaluation of host biomarkers other than interferon gamma in QuantiFERON Plus supernatants as candidates for the diagnosis of tuberculosis in symptomatic individuals. J Infect 2019;79:228-35. [PMID: 31319143 DOI: 10.1016/j.jinf.2019.07.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Alvarez AH. Revisiting tuberculosis screening: An insight to complementary diagnosis and prospective molecular approaches for the recognition of the dormant TB infection in human and cattle hosts. Microbiol Res 2021;252:126853. [PMID: 34536677 DOI: 10.1016/j.micres.2021.126853] [Reference Citation Analysis]
2 Januarie KC, Uhuo OV, Iwuoha E, Feleni U. Recent advances in the detection of interferon-gamma as a TB biomarker. Anal Bioanal Chem 2021. [PMID: 34665279 DOI: 10.1007/s00216-021-03702-z] [Reference Citation Analysis]
3 Perumal P, Abdullatif MB, Garlant HN, Honeyborne I, Lipman M, McHugh TD, Southern J, Breen R, Santis G, Ellappan K, Kumar SV, Belgode H, Abubakar I, Sinha S, Vasan SS, Joseph N, Kempsell KE. Validation of Differentially Expressed Immune Biomarkers in Latent and Active Tuberculosis by Real-Time PCR. Front Immunol 2020;11:612564. [PMID: 33841389 DOI: 10.3389/fimmu.2020.612564] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Namuganga AR, Chegou NN, Mayanja-Kizza H. Past and Present Approaches to Diagnosis of Active Pulmonary Tuberculosis. Front Med (Lausanne) 2021;8:709793. [PMID: 34631731 DOI: 10.3389/fmed.2021.709793] [Reference Citation Analysis]
5 Wilkinson KA, Schneider-Luftman D, Lai R, Barrington C, Jhilmeet N, Lowe DM, Kelly G, Wilkinson RJ. Antiretroviral Treatment-Induced Decrease in Immune Activation Contributes to Reduced Susceptibility to Tuberculosis in HIV-1/Mtb Co-infected Persons. Front Immunol 2021;12:645446. [PMID: 33746987 DOI: 10.3389/fimmu.2021.645446] [Reference Citation Analysis]
6 Madhvi A, Mishra H, Chegou NN, Mkhonza MN, Ndou S, Tromp G, Baker B. Comparison of Cytokines Expression from Human Monocyte-Derived Macrophages Infected with Different Species of Mycobacteria. Journal of Interferon & Cytokine Research. [DOI: 10.1089/jir.2021.0216] [Reference Citation Analysis]
7 Manyelo CM, Solomons RS, Walzl G, Chegou NN. Tuberculous Meningitis: Pathogenesis, Immune Responses, Diagnostic Challenges, and the Potential of Biomarker-Based Approaches. J Clin Microbiol 2021;59:e01771-20. [PMID: 33087432 DOI: 10.1128/JCM.01771-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Shang X, Wang L, Liu Y, Liu X, Lv J, Zhou X, Wang H, Nazierhan S, Wang J, Ma X. Diagnostic value of CXCR3 and its ligands in spinal tuberculosis. Exp Ther Med 2021;21:73. [PMID: 33365073 DOI: 10.3892/etm.2020.9505] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Mann TN, Warwick J, Chegou NN, Davis JH, Beltran CGG, Griffith-Richards S, Kidd M, du Toit J, Lamberts RP, Walzl G. Biomarkers to predict FDG PET/CT activity after the standard duration of treatment for spinal tuberculosis: An exploratory study. Tuberculosis (Edinb) 2021;129:102107. [PMID: 34261033 DOI: 10.1016/j.tube.2021.102107] [Reference Citation Analysis]
10 Eribo OA, Leqheka MS, Malherbe ST, McAnda S, Stanley K, van der Spuy GD, Walzl G, Chegou NN. Host urine immunological biomarkers as potential candidates for the diagnosis of tuberculosis. Int J Infect Dis 2020;99:473-81. [PMID: 32800854 DOI: 10.1016/j.ijid.2020.08.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Koyuncu D, Niazi MKK, Tavolara T, Abeijon C, Ginese ML, Liao Y, Mark C, Specht A, Gower AC, Restrepo BI, Gatti DM, Kramnik I, Gurcan M, Yener B, Beamer G. CXCL1: A new diagnostic biomarker for human tuberculosis discovered using Diversity Outbred mice. PLoS Pathog 2021;17:e1009773. [PMID: 34403447 DOI: 10.1371/journal.ppat.1009773] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Sheffee NS, Rubio-Reyes P, Mirabal M, Calero R, Carrillo-Calvet H, Chen S, Chin KL, Shakimi NAS, Anis FZ, Suraiya S, Sarmiento ME, Norazmi MN, Acosta A, Rehm BHA. Engineered Mycobacterium tuberculosis antigen assembly into core-shell nanobeads for diagnosis of tuberculosis. Nanomedicine 2021;34:102374. [PMID: 33675981 DOI: 10.1016/j.nano.2021.102374] [Reference Citation Analysis]
13 Morris TC, Hoggart CJ, Chegou NN, Kidd M, Oni T, Goliath R, Wilkinson KA, Dockrell HM, Sichali L, Banda L, Crampin AC, French N, Walzl G, Levin M, Wilkinson RJ, Hamilton MS. Evaluation of Host Serum Protein Biomarkers of Tuberculosis in sub-Saharan Africa. Front Immunol 2021;12:639174. [PMID: 33717190 DOI: 10.3389/fimmu.2021.639174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kaforou M. Screening for candidate biomarkers of TB in stimulated blood: another step in the quest for a test? Thorax 2020;75:534-5. [PMID: 32522761 DOI: 10.1136/thoraxjnl-2020-214775] [Reference Citation Analysis]